BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6996132)

  • 1. Inhibition of puerperal lactation: A comparative study of bromocriptine and pyridoxine.
    Boes EG
    S Afr Med J; 1980 May; 57(22):900-3. PubMed ID: 6996132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of puerperal lactation: evaluation of bromocriptine and placebo.
    Bhardwaj N
    Aust N Z J Obstet Gynaecol; 1979 Aug; 19(3):154-7. PubMed ID: 391210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactation suppression with bromocriptine.
    Hutchison P; Sill H
    N Z Med J; 1981 Oct; 94(694):309-10. PubMed ID: 7033847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of puerperal lactation. A double blind study of bromocriptine and placebo.
    Dewhurst CJ; Harrison RF; Biswas S
    Acta Obstet Gynecol Scand; 1977; 56(4):327-31. PubMed ID: 341635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superiority of bromocriptine over pyridoxine in the treatment of patients with acromegaly or galactorrhea.
    Blum I; Segal S; Kaufman H; Sagiv M; Shalit M; Chowers I
    Isr J Med Sci; 1980 Jan; 16(1):12-6. PubMed ID: 7188934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.
    Scapin F; Buonaccorsi S; Tronconi G; Pellicciotta G; Pontiroli AE
    Eur J Clin Pharmacol; 1982; 22(2):181-3. PubMed ID: 7047172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing pyridoxine with dopaminergic agonists (cabergoline and bromocriptine): Unveiling the strategy for lactation inhibition - A systematic review of clinical trials.
    Shrateh ON; Kumar KA; Jawed A; Shuja MH; Shamsi HUR; Naasan M
    J Gynecol Obstet Hum Reprod; 2024 Jun; 53(6):102783. PubMed ID: 38554942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined oral contraceptive pill versus bromocriptine to suppress lactation in puerperium: a randomized double blind study.
    Piya-Anant M; Worapitaksanond S; Sittichai K; Saechua P; Nomrak A
    J Med Assoc Thai; 2004 Jun; 87(6):670-3. PubMed ID: 15279347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of puerperal lactation by bromocriptine.
    Rolland R; Schellekens LA
    Acta Endocrinol Suppl (Copenh); 1978; 216():119-30. PubMed ID: 347857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of bromocriptine and chlorotrianisene in preventing postpartum lactation.
    Yuen BH; Pendleton HJ; Blair S
    Can Med Assoc J; 1977 Oct; 117(8):919-21. PubMed ID: 334356
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of the suppression of lactation and the influence on blood clotting with bromocriptine (CB 154) (Parlodel): a double blind comparison with diethylstilboestrol.
    Nilsen PA; Meling AB; Abildgaard U
    Acta Obstet Gynecol Scand; 1976; 55(1):39-44. PubMed ID: 766555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of dopaminergic drugs (pyridoxine, 2-bromo-alpha-ergocriptine, piribedil) in blocking lactation].
    Lo Dico G; Milia S; Firinu C; Pes F; Masala A; Alagna S; Stoppelli I
    Minerva Ginecol; 1980 Sep; 32(9):771-9. PubMed ID: 7219829
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of lactation by a long-acting bromocriptine.
    Peters F; Del Pozo E; Conti A; Breckwoldt M
    Obstet Gynecol; 1986 Jan; 67(1):82-5. PubMed ID: 3940343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
    BMJ; 1991 Jun; 302(6789):1367-71. PubMed ID: 1676318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The failure of pyridoxine in suppression of puerperal lactation.
    Macdonald HN; Collins YD; Tobin MJ; Wijayarathne DN
    Br J Obstet Gynaecol; 1976 Jan; 83(1):54-5. PubMed ID: 766822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine mesylate for prevention of postpartum lactation.
    Duchesne C; Leke R
    Obstet Gynecol; 1981 Apr; 57(4):464-7. PubMed ID: 7243095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
    Giorda G; de Vincentiis S; Motta T; Casazza S; Fadin M; D'Alberton A
    Gynecol Obstet Invest; 1991; 31(2):93-6. PubMed ID: 2037265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroergocristine in stopping lactation: double-blind study vs bromocriptine.
    de Aloysio D; Pamparana F; Zanotti A; Fabiani AG; Bottiglioni F
    Gynecol Endocrinol; 1988 Mar; 2(1):67-71. PubMed ID: 3140592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Our experience in the inhibition of lactation (Controlled clinical study with bromocriptine, methergoline and pyridoxine)].
    Vecchione A; Baccolo M
    Riv Ital Ginecol; 1980; 59(2-3):311-9. PubMed ID: 7020052
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of lactation.
    Pepperell RJ
    Med J Aust; 1986 Jan; 144(1):37-9. PubMed ID: 3941618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.